Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Olga Rusinovich"'
Autor:
Eva, Galíndez-Agirregoikoa, Diana, Prieto-Peña, José Luis, Martín-Varillas, Beatriz, Joven, Olga, Rusinovich, Rafael B, Melero-González, Francisco, Ortiz-Sanjuan, Raquel, Almodóvar, Juan José, Alegre-Sancho, Ángels, Martínez, Agustí, Sellas-Fernández, Lara, Méndez, Rosario, García-Vicuña, Belén, Atienza-Mateo, Iñigo, Gorostiza, Miguel Ángel, González-Gay, Ricardo, Blanco, María Luz, García-Vivar
Publikováno v:
The Journal of Rheumatology. 48:1552-1558
Objective.Tofacitinib (TOF) is the first Janus kinase (JAK) inhibitor approved for psoriatic arthritis (PsA). It has shown efficacy in patients refractory to anti–tumor necrosis factor-α in randomized controlled trials (RCTs). Our aim was to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65880596297f47a30e7cdb6272b085c8
https://doi.org/10.3899/jrheum.201204
https://doi.org/10.3899/jrheum.201204
Publikováno v:
Revista Colombiana de Reumatología. 28:152-155
Resumen Los nodulos reumatoides benignos son nodulos subcutaneos, identicos en su morfologia e histologia a los que ocurren en el transcurso de la artritis reumatoide (AR), que aparecen en personas sin sintomas de artritis y con factor reumatoide (FR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26750427ad8a3d55e74d435dc67230e4
https://doi.org/10.1016/j.rcreu.2020.05.002
https://doi.org/10.1016/j.rcreu.2020.05.002
Publikováno v:
Revista Colombiana de Reumatología (English Edition). 28:152-155
Benign rheumatoid nodules are subcutaneous nodules, identical in morphology and histology to the nodules that develop over the course of rheumatoid arthritis (RA); they present in individuals with no symptoms of arthritis and with negative rheumatoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a3ec481b0cd8b338aab83f00ab32f90
https://doi.org/10.1016/j.rcreue.2020.05.007
https://doi.org/10.1016/j.rcreue.2020.05.007
Autor:
Carolina Merino Argumánez, José Luis Andreu Sánchez, María Espinosa, Hilda Godoy, Consuelo Ramos Giráldez, Carmen Barbadillo Mateos, Olga Rusinovich
Publikováno v:
Abstracts accepted for Publication.
Background: Gastric angiodysplasia and the typical “watermelon stomach” aspect is one of the most characteristic vascular manifestations in systemic sclerosis (SS). These angiodysplasias can affect the intestine ocasionally as well as the stomach
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e38b491c3390c30be5a04920e13475
https://doi.org/10.1136/annrheumdis-2019-eular.7944
https://doi.org/10.1136/annrheumdis-2019-eular.7944
Autor:
Belén Atienza-Mateo, Esteban Rubio Romero, Ricardo Blanco, Miguel A. González-Gay, Luis Fernández-Dominguez, B. Joven-Ibáñez, Beatriz Arca, Alfonso Corrales, Clara Ventin-Rodriguez, José Luis Martín-Varillas, Jose Campos Esteban, Antia Crespo Golmar, Francisco Ortiz-Sanjuán, Maria Jose Moreno, Manuel Moreno, Eva Galindez, O. Maíz, Rafael Melero, Agusti Sellas-Fernández, Raul Veroz Gonzalez, Enrique Raya, Roberto Daniel Gonzalez Benitez, Olga Rusinovich, Alejandro Escudero Contreras, Emma Beltrán, Vanesa Calvo-Río, Natalia Palmou-Fontana, Javier Loricera, Ximena Elizabeth Larco Rojas, María-Luisa Peral
Publikováno v:
Abstracts accepted for Publication.
Background: Tofacitinib (TOFA) is the first inhibitor of JAK kinases with approval for the treatment of psoriatic arthritis (PsA) in Europe (July 2018)1. ToFA has shown efficacy in refractory patients to anti-TNF2. Objectives: A) to assess efficacy a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bacfa1479a5769dfa23f37f5a822b1c
https://doi.org/10.1136/annrheumdis-2019-eular.7803
https://doi.org/10.1136/annrheumdis-2019-eular.7803
Autor:
Consuelo Ramos Giráldez, María Espinosa, Carolina Merino Argumánez, Carmen Barbadillo Mateos, José Luis Andreu Sánchez, Olga Rusinovich, Fernando León Vázquez, Patricia Fernández Crespo
Publikováno v:
Abstracts Accepted for Publication.
Background: The time of rheumatoid arthritis (RA) evolution until treatment begins is key to controlling the disease. Many studies have shown that a prolonged duration of symptoms at the onset of treatment is associated with a more severe course of R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2166cfacc2a94cfca3f33770d9e8f1d
https://doi.org/10.1136/annrheumdis-2019-eular.6144
https://doi.org/10.1136/annrheumdis-2019-eular.6144
Autor:
Luis Fernando Villa Alcázar, Carolina Merino Argumánez, Consuelo Ramos Giráldez, María Espinosa, Carmen Barbadillo Mateos, Jose Campos Esteban, Carlos Isasi Zaragoza, Hilda Godoy, Jesús Sanz, Olga Rusinovich, Mónica Fernández Castro, José Luis Andreu Sánchez, Mercedes Jiménez Palop
Publikováno v:
Abstracts Accepted for Publication.
Background: Belimumab is a human IgG1l monoclonal antibody directed against BAFF, a B lymphocyte survival factor. It is indicated as adjuvant treatment in adult patients with active systemic lupus erythematosus (SLE), with positive autoantibodies and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34840f6a7e011985ff31c164f69a24a7
https://doi.org/10.1136/annrheumdis-2019-eular.7989
https://doi.org/10.1136/annrheumdis-2019-eular.7989
Autor:
L. Delgado Tellez De Cepeda, Mario Espinosa, Olga Rusinovich, M. Pavía, J.L. Andreu Sánchez, Asunción Mora, N. De La Torre, Josu Sanz, J. Campos Esteban, E. Muñez
Publikováno v:
Annals of the Rheumatic Diseases. 80:892.2-893
Background:SARS-CoV-2 virus is a novel coronavirus that causes COVID-19 disease, which in its most severe form produces life-threatening atypical pneumonia and ARDS. Coronaviruses induce dysregulation of the immune system resulting in a cytokine stor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98c691eedcd8afe9b2f58672e119150a
https://doi.org/10.1136/annrheumdis-2021-eular.2590
https://doi.org/10.1136/annrheumdis-2021-eular.2590
Autor:
Virginia Matallana, Olga Rusinovich, I. Vera, B. Ruiz Antoran, C. Merino Argumánez, C. Ramos Giráldez, J.L. Andreu Sánchez, Josu Sanz, Griselda Uribe Vázquez, J. Campos Esteban, Y. Gonzalez Lama, M I Calvo Moya, N. De La Torre, Mario Espinosa
Publikováno v:
Annals of the Rheumatic Diseases. 79:1142.3-1142
Background:Fecal calprotectin (FC) is a biomarker of bowel inflammation widely spread in diagnosis and follow-up of inflammatory bowel disease (IBD). It is classically estimated that 5% of patients with axial spondyloarthritis (SpA) also have IBD; co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5212a27e953456b63d269ee102ca6832
https://doi.org/10.1136/annrheumdis-2020-eular.5267
https://doi.org/10.1136/annrheumdis-2020-eular.5267
Autor:
José Luis Martín-Varillas, C. Y. Soleto, J. J. Alegre-Sancho, Josep Ramírez, Albert Mas, Mireia Moreno, L. Mendez Diaz, M. A. González-Gay, À. Martínez-Ferrer, Clara Ventin-Rodriguez, I. Gorostiza, Raquel Almodóvar, Olga Rusinovich, X. E. Larco Rojas, A. Crespo Golmar, Diana Prieto-Peña, E. Galindez, R. Garcia de Vicuna, Roman Blanco, B. Joven-Ibáñez, Mabel Moreno, F.M. Ortiz Sanjuan, Natalia Palmou-Fontana, Agusti Sellas-Fernández, M.C. Castro Villegas
Publikováno v:
Annals of the Rheumatic Diseases. 79:1682.1-1682
Background:Tofacitinib (TOFA) is the first JAKi approved for psoriatic arthritis (PsA) in Europe (July 2018). TOFA has shown efficacy in refractory patients to anti-TNF in Randomized Clinical Trials (RCT) (Gladman D. NEJM 2017; 377: 1525-36).Objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::defcfa4bb6fd0531b4f48e667e67664d
https://doi.org/10.1136/annrheumdis-2020-eular.2903
https://doi.org/10.1136/annrheumdis-2020-eular.2903